Differential effects of myoneural blocking drugs on neuromuscular transmission. 1980

N E Williams, and S N Webb, and T N Calvey

The relationship between the depression in the amplitude of the compound muscle action potential and neuromuscular decrement (fade) was studied during the induction of non-depolarizing blockade, using a train of four supramaximal stimuli. Neuromuscular decrement (%) was defined as: [1 - (amplitude of fourth muscle action potential)/(amplitude of first muscle action potential)] x 100. When the amplitude of the first action potential was reduced by 50%, mean neuromuscular decrement increased in the order pancuronium < alcuronium < tubocurarine < frazadinium < gallamine. Similarly, the slope of the regression line relating the decrease in the amplitude of the action potential to decrement was least with pancuronium and greatest with gallamine. These results may reflect different affinities or intrinsic activities of the five drugs for prejunctional and postjunctional receptors. Thus, pancuronium may have a greater affinity for postsynaptic receptors, while tubocurarine and gallamine affect selectively the motor nerve terminal. It was confirmed that fazadinium had a more rapid onset on action than any of the other myoneural blocking drugs studied.

UI MeSH Term Description Entries
D008297 Male Males
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D003473 Neuromuscular Nondepolarizing Agents Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. Curare-Like Agents,Curariform Drugs,Muscle Relaxants, Non-Depolarizing,Neuromuscular Blocking Agents, Competitive,Nondepolarizing Blockers,Agents, Curare-Like,Agents, Neuromuscular Nondepolarizing,Blockers, Nondepolarizing,Curare Like Agents,Drugs, Curariform,Muscle Relaxants, Non Depolarizing,Non-Depolarizing Muscle Relaxants,Nondepolarizing Agents, Neuromuscular
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000768 Anesthesia, General Procedure in which patients are induced into an unconscious state through use of various medications so that they do not feel pain during surgery. Anesthesias, General,General Anesthesia,General Anesthesias
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

N E Williams, and S N Webb, and T N Calvey
October 1984, British journal of anaesthesia,
N E Williams, and S N Webb, and T N Calvey
January 1987, British journal of anaesthesia,
N E Williams, and S N Webb, and T N Calvey
January 1958, British medical bulletin,
N E Williams, and S N Webb, and T N Calvey
April 1973, European journal of pharmacology,
N E Williams, and S N Webb, and T N Calvey
March 2009, Anaesthesia,
N E Williams, and S N Webb, and T N Calvey
December 2002, Journal of the Royal Society of Medicine,
N E Williams, and S N Webb, and T N Calvey
August 1981, Otolaryngologic clinics of North America,
N E Williams, and S N Webb, and T N Calvey
May 1983, Canadian Anaesthetists' Society journal,
N E Williams, and S N Webb, and T N Calvey
June 1979, British journal of anaesthesia,
N E Williams, and S N Webb, and T N Calvey
September 2002, Journal of the Royal Society of Medicine,
Copied contents to your clipboard!